Pulmonary arterial hypertension with right ventricular failure: The left forgotten ventricle

Chest

Volumn 144, Issue 5, 2013, Pages 1435-1436

  Freed, Benjamin H ^b   Gomberg Maitland, Mardi ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; DOBUTAMINE; FUROSEMIDE; SODIUM;

DISEASE EXACERBATION; DISEASE SEVERITY; DRUG USE; ECHOCARDIOGRAPHY; EDITORIAL; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION TIME; HEART MUSCLE ISCHEMIA; HEART RIGHT VENTRICLE FAILURE; HEART SEPTUM DEFECT; HEART STROKE VOLUME; HEART VENTRICLE OVERLOAD; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; TONOMETRY; TREATMENT RESPONSE;

EID: 84887432294     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-1193     Document Type: Editorial

References (12)

1. Voelkel NF, Quaife RA, Leinwand LA, et al; National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation. 2006;114(17):1883-1891.
2. Haddad F, Fuh E, Peterson T, et al. Incidence, correlates, and consequences of acute kidney injury in patients with pulmonary arterial hypertension hospitalized with acute rightside heart failure. J Card Fail. 2011;17(7):533-539.
3. Sztrymf B, Souza R, Bertoletti L, et al. Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension. Eur Respir J. 2010;35(6):1286-1293.
4. Vlahakes GJ, Turley K, Hoffman JI. The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation. 1981;63(1):87-95.
5. Gomberg-Maitland M. Defend the right ventricle with what you know. Eur Respir J. 2010;35(6):1203-1205.
6. Sztrymf B, Günther S, Artaud-Macari E, et al. Left ventricular ejection time in acute heart failure complicating precapillary pulmonary hypertension. Chest. 2013;144(5):1512-1520.
7. Wilkins MR, Paul GA, Strange JW, et al. Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study. Am J Respir Crit Care Med. 2005;171(11):1292-1297.
8. Sciancalepore MA, Maffessanti F, Patel AR, et al. Three-dimensional analysis of interventricular septal curvature from cardiac magnetic resonance images for the evaluation of patients with pulmonary hypertension. Int J Cardiovasc Imaging. 2012;28(5):1073-1085.
9. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89-95.
10. Benza RL, Miller DP, Barst RJ, Badesch DB, Frost AE, McGoon MD. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest. 2012;142(2):448-456.
11. Hoeper MM, Huscher D, Ghofrani HA, et al. Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry [published online ahead of print November 16, 2012]. Int J Cardiol. doi:10.1016/j.ijcard.2012.10.026
12. Gomberg-Maitland M, Michelakis ED. A global pulmonary arterial hypertension registry: is it needed? Is it feasible? Pulmonary vascular disease: the global perspective. Chest. 2010;137(6suppl):95S-101S.